Susquehanna Fundamental Investments’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
Other funds holding GTBP
N
Susquehanna Fundamental Investments's GTBP Position: Q1 2022 in Review
Susquehanna Fundamental Investments reduced its GT Biopharma (GTBP) stake by 2.1% in Q1 2022, selling an estimated $1.76K and leaving 942 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #1472.
Susquehanna Fundamental Investments first reported a position in GTBP in Q3 2021 and has held it in 3 quarters since. The position peaked at $96K in Q3 2021. 57 funds tracked by Wall St. Rank hold GTBP as of Q1 2022.
- Susquehanna Fundamental Investments held 942 shares of GT Biopharma worth $81K as of Q1 2022.
- Susquehanna Fundamental Investments sold 20 GT Biopharma shares in Q1 2022, an estimated $1.76K.
- GT Biopharma made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1472 holding.
- Susquehanna Fundamental Investments first reported a position in GT Biopharma in Q3 2021 and has held it in 3 quarters since.
- Susquehanna Fundamental Investments's GT Biopharma position peaked at $96K in Q3 2021.
- 57 funds tracked by Wall St. Rank held GT Biopharma as of Q1 2022.
Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.